Gender differences in symptomatic profiles of depression: Results from the Sao Paulo Megacity Mental Health Survey

Carregando...
Imagem de Miniatura
Citações na Scopus
50
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE BV
Autores
VIANA, Maria Carmen
BULHOES, Rodrigo S.
MARTINS, Silvia S.
Citação
JOURNAL OF AFFECTIVE DISORDERS, v.147, n.1-3, p.355-364, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Few studies have investigated symptomatic subtypes of depression and their correlates by gender. Methods: Data are from the Sao Paulo Megacity Mental Health Survey. Symptom profiles of 1207 subjects (864 women; 343 men) based upon symptoms of the worst depressive episode in lifetime were examined through latent class analysis. Correlates of gender-specific latent classes were analyzed by logistic regression. Results: For both men and women, a 3-class model was the best solution. A mild class was found in both genders (41.1% in women; 40.1% in men). Gender differences appeared in the most symptomatic classes. In women, they were labeled melancholic (39.3%) and atypical (19.5%), differing among each other in somatic/vegetative symptoms. The melancholic class presented inhibition and eating/sleeping symptoms in the direction of decreasing, whereas the atypical class had increased appetite/weight, and hypersomnia. For men, symptoms that differentiate the two most symptomatic classes were related to psychomotor activity: a melancholic/psychomotor retarded (40.4%) and agitated depression (19.6%). The highest between-class proportion of agitation and racing thoughts was found among men in the agitated class, with similarity to bipolar mixed state. Limitations: Analyses were restricted to those who endorsed questions about their worst lifetime depressive episode; the standardized assessment by lay interviewers; the small male sample size. Conclusions: The construct of depression of current classifications is heterogeneous at the symptom level, where gender different subtypes can be identified. These symptom profiles have potential implications for the nosology and the therapeutics of depression.
Palavras-chave
Subtypes of depression, Depressive symptoms, Depression, Mental disorders, Population-based study, Gender differences
Referências
  1. Akiskal HS, 2005, J AFFECT DISORDERS, V85, P245, DOI 10.1016/j.jad.2004.12.004
  2. Alonso J, 2011, MOL PSYCHIATR, V16, P1234, DOI 10.1038/mp.2010.101
  3. Angst J, 2001, ACTA PSYCHIAT SCAND, V104, P110, DOI 10.1034/j.1600-0447.2001.00412.x
  4. Angst J, 2002, J AFFECT DISORDERS, V72, P125, DOI 10.1016/S0165-0327(02)00169-6
  5. Angst J, 1997, J AFFECT DISORDERS, V45, P39
  6. APA, 1994, DIAGN STAT MAN MENT
  7. APA, 2012, DSM 5 DEV MIX FEAT S
  8. AVERY D, 1984, J AFFECT DISORDERS, V7, P67, DOI 10.1016/0165-0327(84)90066-1
  9. Benazzi F, 2001, J AFFECT DISORDERS, V67, P115, DOI 10.1016/S0165-0327(01)00444-X
  10. Benazzi F, 2003, PSYCHOPATHOLOGY, V36, P213, DOI 10.1159/000072792
  11. Benazzi F, 2004, PROG NEURO-PSYCHOPH, V28, P1279, DOI 10.1016/j.pnpbp.2004.06.018
  12. Benazzi F, 2002, PSYCHIAT RES, V112, P211, DOI 10.1016/S0165-1781(02)00241-X
  13. Bruffaerts R, 2012, BRIT J PSYCHIAT, V200, P454, DOI 10.1192/bjp.bp.111.097519
  14. Carragher N, 2009, J AFFECT DISORDERS, V113, P88, DOI 10.1016/j.jad.2008.05.015
  15. Chen LS, 2000, J AFFECT DISORDERS, V59, P1, DOI 10.1016/S0165-0327(99)00132-9
  16. Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566
  17. Eaton WW, 2008, EPIDEMIOL REV, V30, P1, DOI 10.1093/epirev/mxn011
  18. EATON WW, 1989, BRIT J PSYCHIAT, V155, P48, DOI 10.1192/bjp.155.1.48
  19. Epperson CN, 2012, AM J PSYCHIAT, V169, P465, DOI 10.1176/appi.ajp.2012.11081302
  20. Fava M, 2010, MOL PSYCHIATR, V15, P856, DOI 10.1038/mp.2009.20
  21. Forrester-Knauss C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-795
  22. Freeman EW, 2011, OBSTET GYNECOL, V118, P1293, DOI 10.1097/AOG.0b013e318236edf2
  23. HABERMAN SJ, 1973, BIOMETRICS, V29, P205, DOI 10.2307/2529686
  24. Hagenaars J., 2002, APPL LATENT CLASS AN
  25. HALBREICH U, 1995, ARCH GEN PSYCHIAT, V52, P606
  26. Halbreich U., 2006, PSYCHONEUROENDOCRINO, V31, P23
  27. Halbreich U, 2007, J AFFECT DISORDERS, V102, P245, DOI 10.1016/j.jad.2006.09.023
  28. HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278
  29. Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830
  30. Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506
  31. Hildebrandt MG, 2003, ACTA PSYCHIAT SCAND, V107, P197, DOI 10.1034/j.1600-0447.2003.02108.x
  32. Hildebrandt MG, 2003, PSYCHOPATHOLOGY, V36, P204, DOI 10.1159/000072791
  33. Husky MM, 2008, DRUG ALCOHOL DEPEN, V93, P176, DOI 10.1016/j.drugalcdep.2007.07.015
  34. IBGE, 2001, CENS DEM POP 2000
  35. Joyce PR, 2008, AUST NZ J PSYCHIAT, V42, P851, DOI 10.1080/00048670802363667
  36. Kendler KS, 1996, ARCH GEN PSYCHIAT, V53, P391
  37. KESSLER RC, 1994, J AFFECT DISORDERS, V30, P15, DOI 10.1016/0165-0327(94)90147-3
  38. Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168
  39. Kessler RC, 1997, J AFFECT DISORDERS, V45, P19, DOI 10.1016/S0165-0327(97)00056-6
  40. Keyes KM, 2011, ALCOHOL CLIN EXP RES, V35, P2101, DOI 10.1111/j.1530-0277.2011.01562.x
  41. Khan AA, 2002, AM J PSYCHIAT, V159, P1427, DOI 10.1176/appi.ajp.159.8.1427
  42. Klein DN, 2008, J ABNORM PSYCHOL, V117, P552, DOI 10.1037/0021-843X.117.3.552
  43. Korhonen T, 2007, PSYCHOL MED, V37, P705, DOI 10.1017/S0033291706009639
  44. Korhonen T, 2011, NICOTINE TOB RES, V13, P261, DOI 10.1093/ntr/ntq251
  45. Kornstein SG, 2000, J AFFECT DISORDERS, V60, P1, DOI 10.1016/S0165-0327(99)00158-5
  46. Kraepelin E, 1921, MANIC DEPRESSIVE INS
  47. Krueger RF, 2009, WORLD PSYCHIATRY, V8, P3
  48. Lamers F, 2010, J CLIN PSYCHIAT, V71, P1582, DOI 10.4088/JCP.09m05398blu
  49. Landen M, 2003, DEPRESS ANXIETY, V17, P122, DOI 10.1002/da.10089
  50. Lawrence D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-285
  51. Lazarsfeld PF, 1968, LATENT STRUCTURE ANA
  52. Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1
  53. LIVSON N, 1988, INT J ADDICT, V23, P535
  54. Marcus SM, 2005, J AFFECT DISORDERS, V87, P141, DOI 10.1016/j.jad.2004.09.008
  55. Marcus SM, 2008, COMPR PSYCHIAT, V49, P238, DOI 10.1016/j.comppsych.2007.06.012
  56. Martins SS, 2011, DRUG ALCOHOL DEPEN, V119, P28, DOI 10.1016/j.drugalcdep.2011.05.010
  57. Matza LS, 2003, ARCH GEN PSYCHIAT, V60, P817, DOI 10.1001/archpsyc.60.8.817
  58. McKee SA, 2003, ADDICTION, V98, P847, DOI 10.1046/j.1360-0443.2003.00408.x
  59. Meltzer H., 2012, SOCIAL PSYCHIAT PSYC
  60. Mezuk B., 2012, PSYCHOL MED, P1
  61. Miller NS, 1996, J PSYCHOACTIVE DRUGS, V28, P111
  62. Moreno DH, 2010, J AFFECT DISORDERS, V123, P208, DOI 10.1016/j.jad.2009.09.023
  63. Muthen LK, 1998, MPLUS USERS GUIDE
  64. Nakamura K, 2009, TOB CONTROL, V18, P345, DOI 10.1136/tc.2008.028795
  65. Nandi A, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-31
  66. Neuman RJ, 2001, J CHILD PSYCHOL PSYC, V42, P933, DOI 10.1111/1469-7610.00789
  67. Nylund KL, 2007, STRUCT EQU MODELING, V14, P535
  68. Parker G, 2000, J AFFECT DISORDERS, V59, P217, DOI 10.1016/S0165-0327(99)00144-5
  69. Parker G, 2006, CAN J PSYCHIAT, V51, P879
  70. Parker G, 2000, AM J PSYCHIAT, V157, P1195, DOI 10.1176/appi.ajp.157.8.1195
  71. Patten SB, 2011, CAN J PSYCHIAT, V56, P658
  72. PAYKEL ES, 1983, PSYCHOL MED, V13, P131
  73. Pier MPBI, 2004, J PSYCHIAT RES, V38, P425, DOI 10.1016/j.jpsychires.2003.11.008
  74. POLLITT JD, 1965, BRIT J PSYCHIAT, V111, P489, DOI 10.1192/bjp.111.475.489
  75. Rogers MA, 2002, J CLIN EXP NEUROPSYC, V24, P101, DOI 10.1076/jcen.24.1.101.974
  76. Sanchez-Gistau V, 2009, ACTA PSYCHIAT SCAND, V120, P30, DOI 10.1111/j.1600-0447.2008.01341.x
  77. Sargant W., 1960, PSYCHOSOMATICS, V1, P4
  78. Scheibe S, 2003, J AFFECT DISORDERS, V75, P223, DOI 10.1016/S0165-0327(02)00050-2
  79. Schrijvers D, 2008, J AFFECT DISORDERS, V109, P1, DOI 10.1016/j.jad.2007.10.019
  80. Scott KM, 2006, AUST NZ J PSYCHIAT, V40, P889, DOI 10.1080/j.1440-1614.2006.01908.x
  81. Scott KM, 2009, PSYCHOL MED, V39, P33, DOI 10.1017/S0033291708003188
  82. Silveira CM, 2007, J STUD ALCOHOL DRUGS, V68, P18
  83. SILVEIRA CM, 2011, BRAZILIAN ALCOHOL AL, V46, P324, DOI 10.1093/ALCALC/AGR007
  84. Silverstein B., 2012, SOCIAL PSYCHIAT PSYC
  85. Silverstein B, 1999, AM J PSYCHIAT, V156, P480
  86. Sobin C, 1997, AM J PSYCHIAT, V154, P4
  87. Sullivan PF, 1998, AM J PSYCHIAT, V155, P1398
  88. Sullivan PF, 2002, J AFFECT DISORDERS, V68, P273, DOI 10.1016/S0165-0327(00)00364-5
  89. van Praag HM, 2008, EUR ARCH PSY CLIN N, V258, P29, DOI 10.1007/s00406-008-2006-1
  90. Viana MC, 2009, REV BRAS PSIQUIATR, V31, P375, DOI 10.1590/S1516-44462009000400016
  91. Weich S, 2011, PSYCHOL MED, V41, P2201, DOI 10.1017/S0033291711000249
  92. WEST ED, 1959, BRIT MED J, V1, P1491
  93. WINOKUR G, 1973, COMPR PSYCHIAT, V14, P99, DOI 10.1016/0010-440X(73)90002-3
  94. Yates F., 1934, JR STATIST SOC S, V1, P217, DOI 10.2307/2983604
  95. Zilberman M, 2003, J ADDICT DIS, V22, P61, DOI 10.1300/J069v22n04_06
  96. American Psychiatric Association, 1987, DIAGN STAT MAN MENT